Brazil Cancer Research
Latin America's Research Powerhouse & CAR-T Hub
Death Risk Reduction
Breast cancer breakthrough
CAR-T Hub in Latin America
Regional manufacturing
Lower Treatment Costs
Affordable radiation tech
40% Death Risk Reduction in Breast Cancer
Brazilian researchers achieved a 40% reduction in breast cancer death risk through early detection programs combined with rapid treatment access.
Impact:
Saving thousands of Brazilian women annually
CAR-T Manufacturing Hub for Latin America
Brazil established Latin America's first CAR-T cell therapy manufacturing facility, producing affordable treatments for the entire region.
Impact:
Bringing advanced immunotherapy to South America
Pioneering Zika-Cancer Connection Research
Brazilian scientists discovered that Zika virus can selectively kill brain cancer cells, opening new avenues for viral therapy.
Impact:
Novel viral approach to treating glioblastoma
Affordable Radiation Therapy Technology
Brazil developed cost-effective linear accelerators for radiation therapy at 50% lower cost, making treatment accessible across South America.
Impact:
Expanding radiation access to underserved regions
Tropical Disease-Cancer Interaction Studies
Brazil leads research on how tropical infections affect cancer development and treatment, critical for understanding cancer in tropical regions.
Impact:
Tailoring cancer care for tropical populations
International Clinical Trial Partnerships
Brazil hosts major international clinical trials, offering Brazilian patients early access to experimental therapies from US and European pharmaceutical companies.
Impact:
Bringing global innovation to South America
A.C.Camargo Cancer Center
São Paulo
Brazil's premier cancer hospital. Leading research in breast, colorectal, and head/neck cancers. Strong partnerships with US and European institutions.
Key Specialties:
Instituto Nacional de Câncer (INCA)
Rio de Janeiro
Brazil's national cancer institute. Public health oncology, tropical disease-cancer interactions, and affordable treatment development.
Key Specialties:
Hospital Sírio-Libanês
São Paulo
Latin America's CAR-T therapy hub. Precision medicine and advanced immunotherapy for the region.
Key Specialties:
Brazil welcomes international patients to cutting-edge clinical trials
CAR-T for Lymphoma (Latin American Study)
Testing Brazilian-manufactured CAR-T cells for non-Hodgkin lymphoma patients across Latin America.
Zika Virus Therapy for Brain Tumors
Using engineered Zika virus to selectively attack glioblastoma cells while sparing healthy brain tissue.
Breast Cancer Early Detection Program
Nationwide breast cancer screening and rapid treatment program aiming to reduce mortality by 50%.
